NCDL
name pending profile ingest
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +20.6% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 87.54K | $953,300 | n/a | n/a |
| Q2 2026 | 25 | 0 | 6.14M | $76.36M | +4 | −4 |
| Q1 2026 | 25 | -2 | 6.35M | $80.81M | +3 | −5 |
| Q4 2025 | 27 | 0 | 8.12M | $108.41M | +1 | −1 |
| Q3 2025 | 7 | +1 | 1.59M | $21.95M | +1 | n/a |
| Q2 2025 | 4 | -2 | 599.03K | $9.70M | n/a | −2 |
| Q1 2025 | 6 | +1 | 1.48M | $25.15M | +1 | n/a |
| Q4 2024 | 5 | 0 | 1.23M | $20.65M | n/a | n/a |
| Q3 2024 | 5 | 0 | 362.27K | $6.31M | n/a | n/a |
| Q2 2024 | 5 | n/a | 300.28K | $5.22M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 108.80K | +248.7% | $1.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Millennium Management ✦ | 94.88K | +7.9% | $1.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 66.26K | -8.1% | $1.15M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Marshall Wace ✦ | 47.85K | -39.8% | $833,634 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 44.47K | +50.4% | $774,720 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 66 holders, 15.23M shares, $185.29M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Officer · Chief Financial… · 5.00K sh @ 12.25 · $61,250
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology